Clinical efficacy and safety of the ealry intervention with Tolvaptan(V2 receptorinhibiter)in hospitalized patients with acute exacerbation of chronic heart failur:A randomized open-labeled parallel controlled study
Latest Information Update: 10 Jan 2020
At a glance
- Drugs Tolvaptan (Primary) ; Loop diuretics
- Indications Heart failure
- Focus Therapeutic Use
- 08 Jan 2020 Status changed from recruiting to discontinued.
- 28 Jan 2014 New trial record